All work, no play, makes LIKELIHOOD OF CONFUSION® a dull boy. So I am in New England trying to stay… sharp.
Author:Ron ColemanI write this blog.
If you don't get enough email (who does?), I can send you LIKELIHOOD OF CONFUSION® blog posts by email! Free!
Leave a Reply
The question of whether consumers are likely to be confused is the signal inquiry that determines if a trademark infringement claim is valid. This blog is about trademark law, copyright law, free speech (mostly as it relates to the Internet) and legal issues related to blogging.As for me, I'm a partner and commercial litigator at Goetz Fitzpatrick LLP in New York and, some say, "IP maven" with a special interest in copyright and trademark infringement involving the Internet--including advising clients how to avoid them. click here.
Follow @likely2confuse on Twitter
Matthew David Brozik – Contributing Editor
If you want to read something terrific, Matthew David Brozik's website is the place to spend time. Sometimes, however -- now, on a regular basis -- he saves something for LIKELIHOOD OF CONFUSION®.
Besides being an actual writer, Matthew is also an actual lawyer, his intellectual property law bibliography not being for nothing.
I’m high-ranked and I know it.
Is LIKELIHOOD OF CONFUSION® really all that? Rankings-wise? Is it really one of the top law blogs in the galaxy?
It is, for what that's worth.
As of right now, here are the latest rankings via:
- All legal blogs on Avvo.com
- Most popular law blogs this month on Justia (sometimes)
- All IP law blogs, by popularity, on Justia
- All copyright law blogs, by popularity on Justia (whoa!)
- Alltop's law blogs and
- Cision.com's Top 50 Law Blogs
It's easy it is to game almost any ranking system, not that I've tried to. As such. These are just what they are.
The term of art maven is used to mean "wise guy" here and is not meant to suggest that I have certified or other "expertise" in any particular field of legal practice. But try me.
CATEGORIES (a work in progress)
- Apotex v Sanofi: manner of manufactureApotex v Sanofi: Sanofi's patent for a second use of leflunomide is patentable subject matter in AustraliaWarwick Rothnie
- Brand protection goes beyond domain namesIntellectual property lawyers are all to familiar with the phone call from a new client ambushed with the news that a business domain name can no longer be used. This unhappy client has invested thousands, tens of thousands or more on brand development. Included in this is time, energy and money spent on a business name, a domain name, logo and brand design, […]Noric Dilanchian
- T 2134/12 – Just Keep ItIn this case the Examining Division (ED) granted interlocutory revision and then sent the case to the Board of appeal for a decision on reimbursement of the appeal fee. So far so good. There was only one problem – the appellant had never asked to be reimbursed. *** Translation of the German original ***  Pursuant to R 103(2) the department whose decision […]oliver randl
- Eight Tech Giants Call for Reform to Surveillance LawToday, there are full-page advertisements running in the New York Times, Washington Post, Politico, Roll Call, and The Hill. They all have the same message: big tech companies are calling on Congress to rein in the mass surveillance. You can read the full message on the newly-launched Reform Government Surveillance site. This is a victory for users—with the […]Kurt Opsahl and Rainey Reitman
- Powerless Portals Pare Ownership Report Filing PeriodDeadline trimmed by five hours. Hey, all you procrastinating commercial broadcasters. You know who you are. Listen up. Even though the FCC gave you (and everybody else) an extra 18 days – to December 20 – to file your biennial Ownership Reports (FCC Form 323), that deadline has now been modified slightly. While ordinarily your reports could have been filed u […]FHH Law
- EFF Asks Supreme Court to Expand Fee Shifting in Patent CasesToday, EFF—along with Engine, the App Developers Alliance, and Public Knowledge—filed a brief asking the Supreme Court to retain some sanity in the law and tighten up the rules around fee shifting. Fee shifting, sometimes called "loser pays," is already in the Patent Act. While the statute currently says that "the court in exceptional cases ma […]Julie Samuels and Julie Samuels
LIKELIHOOD OF CONFUSION® Copyright © 2013. All Rights Reserved.